Cargando…
Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy
BACKGROUND: Doxorubicin‐based chemotherapy after splenectomy remains the standard of care for hemangiosarcoma in dogs, but prognosis is generally poor. HYPOTHESIS/OBJECTIVES: To determine clinical outcome with carboplatin chemotherapy after splenectomy compared to doxorubicin‐based protocols. A seco...
Autores principales: | Faulhaber, Erica A., Janik, Emily, Thamm, Douglas H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295674/ https://www.ncbi.nlm.nih.gov/pubmed/34227148 http://dx.doi.org/10.1111/jvim.16212 |
Ejemplares similares
-
Erratum for “Adjuvant carboplatin for treatment of splenic hemangiosarcoma in dogs: Retrospective evaluation of 18 cases (2011‐2016) and comparison with doxorubicin‐based chemotherapy”
Publicado: (2021) -
Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide
por: McNally, Abigail, et al.
Publicado: (2023) -
Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy
por: Latifi, Max, et al.
Publicado: (2020) -
Clinical relevance of splenic nodules or heterogeneous splenic parenchyma assessed by cytologic evaluation of fine‐needle samples in 125 dogs (2011‐2015)
por: Yankin, Igor, et al.
Publicado: (2019) -
Prevalence, distribution, and clinical characteristics of hemangiosarcoma‐associated skeletal muscle metastases in 61 dogs: A whole body computed tomographic study
por: Carloni, Andrea, et al.
Publicado: (2019)